On July 21, Novo Nordisk filed a lawsuit against Eli Lilly in the US federal court, accusing Eli Lilly of misleading content in advertisements for its celebrity diet drug Zepbound and the hypoglycemic drug Mounjaro.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.